G01N 2333/91171
With definite ec number
Official title: with definite EC number (2.5.1.-)
G01N2333/91171 (With definite ec number) appears on 47 US grants and 113 published applications in this corpus.
Search patents in G01N- Granted patents
- 47
- Published applications
- 113
- Assignees
- 96
- Inventors
- 221
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 3 |
| 2003 | 1 | 9 |
| 2004 | 2 | 4 |
| 2005 | 1 | 2 |
| 2006 | 0 | 2 |
| 2007 | 0 | 1 |
| 2008 | 1 | 2 |
| 2009 | 0 | 4 |
| 2010 | 1 | 2 |
| 2011 | 0 | 13 |
| 2012 | 1 | 6 |
| 2013 | 2 | 3 |
| 2014 | 4 | 4 |
| 2015 | 3 | 11 |
| 2016 | 1 | 4 |
| 2017 | 4 | 7 |
| 2018 | 4 | 6 |
| 2019 | 2 | 5 |
| 2020 | 3 | 4 |
| 2021 | 1 | 3 |
| 2022 | 2 | 4 |
| 2023 | 2 | 6 |
| 2024 | 1 | 2 |
| 2025 | 2 | 3 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Systems and methods for sensing analytes in GMR-based detection of biomarkers30 Jun 2026US 12,667,844 B2Zepto Life Technology, Inc.
- Therapeutic small molecules for treatment of pulmonary hypertension14 Apr 2026US 12,599,592 B2The Texas A&M University System
- Markers and their use in brain injury23 Sep 2025US 12,422,442 B2Fundació Hospital Universitari Vall D'Hebron—Institut De Recerca
- Assays and methods for targeted treatment of hydrosalpinx29 Apr 2025US 12,287,341 B2The Government of the United States, as represented by the Secretary of the Army
- Probe for selectively characterizing enzymes involved in xenobiotic metabolism and method of making and using the same6 Feb 2024US 11,891,655 B2Battelle Memorial Institute
- Method20 Aug 2026US 2026/0243781 A1Philip Morris Products S. A.
- Catlytically modified enzyme-based biosensors and methods of production thereof4 Jun 2026US 2026/0153494 A1Agricul Tural University of Athens
- Therapeutic agent for treating hif-1alpha-mediated diseases by inhibiting arel1 and restoring phd2 activity7 May 2026US 2026/0125685 A1Biochemgen Inc.
- Apparatus for measuring enzyme activity using substrate-immobilized carrier with non-uniform substrate immobilization density and method thereof4 Dec 2025US 2025/0369033 A1Canon Medical Systems Corporation
- Methods for diagnosis and treatment of alzheimer's disease28 Aug 2025US 2025/0270618 A1Children's Medical Center Corporation
Most cited
By later US patents
- Molecular sensor and methods of use thereof35US 9,696,310 B2Yeda Research and Development Co. Ltd. · 2017
- Glutathione analogs as reagents28US 6,013,462 ATerrapin Technologies, Inc. · 2000
- Glutathione S-transferase-activated compounds24US 5,556,942 ATerrapin Technologies, Inc. · 1996
- Glutathione analogs and paralog panels comprising glutathione mimics18US 5,599,903 ATerrapin Technologies, Inc. · 1997
- Glutathione analogs and paralog panels comprising glutathione mimics14US 5,763,570 ATerrapin Technologies, Inc. · 1998